Under certain conditions, CD11b+Ly6G+ cells can dampen the inflammatory response through inhibiting T cell responses (41), and CD11b+Ly6G+ cells will be used clinically as an anti-inflammatory cell subtype, especially during acute virus infection. Here, ITGAM is linked to viral infectious disease.